Progression-Free Survival (PFS) Baseline, every 2nd cycle (between Day 15-21, 1 cycle = 21 days) starting with Cycle 2 until disease progression, at the end of treatment visit (if more than 28 days have passed since last evaluation); and every 6 weeks until disease progression [clinicaltrials_resource:93a493a3dbe747e49f3744f5bcf2f30b]
Median time from the first dose of study treatment to the first documentation of objective tumor progression or to death due to any cause, whichever occurs first. PFS time (days) = [event (progression or death) date or censor date - date of randomization + 1].
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Progression-Free Survival (PFS) Baseline, every 2nd cycle (between Day 15-21, 1 cycle = 21 days) starting with Cycle 2 until disease progression, at the end of treatment visit (if more than 28 days have passed since last evaluation); and every 6 weeks until disease progression [clinicaltrials_resource:93a493a3dbe747e49f3744f5bcf2f30b]
Median time from the first dose of study treatment to the first documentation of objective tumor progression or to death due to any cause, whichever occurs first. PFS time (days) = [event (progression or death) date or censor date - date of randomization + 1].
Bio2RDF identifier
93a493a3dbe747e49f3744f5bcf2f30b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:93a493a3dbe747e49f3744f5bcf2f30b
measure [clinicaltrials_vocabulary:measure]
Progression-Free Survival (PFS)
time frame [clinicaltrials_vocabulary:time-frame]
Baseline, every 2nd cycle (bet ...... eeks until disease progression
description
Median time from the first dos ...... - date of randomization + 1].
identifier
clinicaltrials_resource:93a493a3dbe747e49f3744f5bcf2f30b
title
Progression-Free Survival (PFS ...... eeks until disease progression
@en
type
label
Progression-Free Survival (PFS ...... 493a3dbe747e49f3744f5bcf2f30b]
@en